AOD 9604 and Research in Cancer Cells The peptide may be able to bind (target) tumor-related proteins to enhance tumor drug accumulation and local cytotoxicity
Some practitioners in the peptide community do recommend stacking AOD 9604 with GLP-1 agonists, particularly for patients who want to maximize fat loss while minimizing muscle loss
That is the main benchmark window in the tesamorelin literature
Metformin enhancement of therapeutic effects of 5-fluorouracil and oxaliplatin in colon cancer cells and nude mice
It enhances key immune responses, including natural killer cell cytotoxicity, neutrophil phagocytosis, and monocyte activity (Simpson et al., 2015) while also promoting immunosurveillance (Lee et al., 2019), decreasing the number of senescent cells (Spielmann et al., 2011), and suppressing signaling pathways that promote stem cell exhaustion (Liu et al., 2023)